TORONTO, ON / ACCESSWIRE / July 26, 2016 / NOVADAQ Technologies Inc. (NASDAQ: NVDQ) (TSX: NDQ) will host a conference call and live webcast to discuss the results of the second quarter 2016, to be held Wednesday, July 27, 2016 at 4:30 PM Eastern Time.

To participate in this event, dial 877-407-8031 domestically, or 201-689-8031 internationally, approximately 5 to 10 minutes before the beginning of the call. Additionally, you can listen to the event online at www.investorcalendar.com/IC/CEPage.asp?ID=175148 as well as via the NOVADAQ website (novadaq.com).

If you are unable to participate during the live webcast, the event archive will be available at www.investorcalendar.com or novadaq.com.

You may access the teleconference replay by dialing 877-660-6853 domestically or 201-612-7415 internationally, referencing conference ID # 13641209. The replay will be available beginning approximately 2 hours after the completion of the live event, ending at midnight Eastern on August 27, 2016.

About Novadaq Technologies Inc.

Enabling medical professionals with clinically relevant, point-of-care imaging solutions to enhance the lives of patients and their caregivers, while reducing health care costs, is NOVADAQ’s global mission. SPY fluorescence imaging technology provides surgeons with real-time visualization, leading to improved outcomes and reduced costs without exposing the patient to radiation. More than 180 peer-reviewed publications demonstrate that the use of SPY imaging technologies during complex surgery and diagnostic procedures, leads to lower rates of post-operative complications and lower hospital costs.

SPY Imaging Systems are United States Food and Drug Administration 510(k) cleared for use in seven surgical specialties. The endoscopic version of SPY called PINPOINT, combines the capabilities of SPY Imaging with high definition (“HD”) visible light visualization offered by conventional endoscopes. LUNA is used to assess perfusion in patients being treated for non-healing wounds. In December 2014, NOVADAQ and LifeNet Health jointly announced the signing of a multi-year agreement appointing NOVADAQ the exclusive worldwide distributor of LifeNet Health’s DermACELL acellular tissue products for wound and breast reconstruction surgery.

SOURCE: Investor Calendar

ReleaseID: 442820

GRAND CAYMAN, CAYMAN ISLANDS / ACCESSWIRE / July 26, 2016 / Oxbridge (NASDAQ: OXBR) plans to hold a conference call on Monday, August 15, 2016 at 4:30 p.m. Eastern time to discuss results for the second quarter ended June 30, 2016. Financial results will be issued in a press release after the close of the market on the same day.

Oxbridge’s management will host the presentation, followed by a question and answer period.

Interested parties can listen to the live presentation by dialing the listen-only number below or by clicking the webcast link available on the Investor Information section of the company’s website at www.oxbridgere.com.

Date: Monday, August 15, 2016
Time: 4:30 p.m. Eastern time
Listen-only toll-free number: 877-407-0782
Listen-only international number: 201-689-8567
Conference ID: 13642405

Please call the conference telephone number 10 minutes before the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Precision IR at 919-481-4000 or operations@issuerdirect.com.

A replay of the call will be available by telephone after 8:00 p.m. Eastern time on the same day of the call and via the Investor Information section of Oxbridge’s website at www.oxbridgere.com until September 15, 2016.

Toll-free replay number: 877-660-6853
International replay number: 201-612-7415
Conference ID: 13642405

About Oxbridge Re Holdings Limited

Oxbridge (www.oxbridgere.com) is a Cayman Islands exempted company that was organized in April 2013 to provide reinsurance business solutions primarily to property and casualty insurers in the Gulf Coast region of the United States. Through Oxbridge’s licensed reinsurance subsidiary, Oxbridge Reinsurance Limited, it writes fully collateralized policies to cover property losses from specified catastrophes. Oxbridge specializes in underwriting medium frequency, high severity risks, where it believes sufficient data exists to analyze effectively the risk/return profile of reinsurance contracts. The company’s ordinary shares and warrants trade on the NASDAQ Capital Market under the symbols “OXBR” and “OXBRW,” respectively.

Company Contact:

Oxbridge Re Holdings Limited
Jay Madhu, CEO
345-749-7570
jmadhu@oxbridgere.com

Media Contact:

Suzie Boland
RFB Communications Group
813-259-0345
sboland@rfbcommunications.com

SOURCE: Oxbridge Re Holdings Limited

ReleaseID: 442876

JAMAICA, NY / ACCESSWIRE / July 26, 2016 / Baltia Air Lines, Inc. (OTC: BLTA) announced today that it has signed an agreement with CP Capital Securities, Inc. to serve as financial advisors and to provide innovative financial solutions to Baltia Air Lines in order for Baltia to continue with FAA Air Carrier Certification and to secure aircraft.

Per the terms of the agreement CP Capital Securities shall advise and assist Baltia in negotiating the terms and conditions of any transaction and perform such other financial advisory services as CP Capital Securities and Baltia may from time to time agree upon.

Baltia’s President, Mr. Russell Thal stated, “We look forward to working with CP Capital so that we can complete the FAA Part 121 Air Carrier Certification. I also want to thank all of our employees and shareholders for their support while our finance team worked diligently locating a firm such as CP Capital Securities to provide the advisory platform necessary to getting us back on track to complete all of the necessary tasks needed to obtain our certificate and begin flight revenue service.”

About CP Capital Securities, Inc.

CP Capital Securities is a financial services firm serving clients worldwide with access to innovative financial solutions and commitment to excellence. As a fully service broker-dealer and investment adviser, CP Capital offers a full complement of wealth management and capital markets services to private clients and institutional clients.

CP Capital’s banking executives have acted as arrangers and advisors on various global and cross-industry capital market transactions throughout their careers. These executives come from large corporate & financial institutions, where they adopted financial best practice policies as well as learned to devise innovative solutions to major corporate challenges.

CP Capital’s Investment Banking division focuses on providing advisory services to growth oriented companies. The group’s structuring capabilities are focused on addressing and providing innovative solutions to complex issues and challenges for clients across the globe. Our Investment Banking team specializes in tailoring efficient and cost-effective corporate finance solutions, from restructuring balance sheets, financial restructuring, to M&A and other value-added services.

About Baltia

Baltia Air Lines, Inc. is a New York corporation with headquarters in Terminal 4 at JFK International Airport in New York and a base of operations at Willow Run Airport in Ypsilanti, MI. Baltia’s goal is become a U.S. airline serving the international market between the U.S and cities that participate under an Open Skies Treaty/Agreement. Baltia’s objective is to provide quality passenger service, reliable cargo and mail transportation. Baltia plans to begin their foreign scheduled air transportation as the only U.S. airline, connecting directly, to two of the world’s most prominent cities — New York and St. Petersburg, Russia.

D.O.T. Regulatory Disclaimer:

Baltia is a U.S. startup airline. No ticket sales are currently available. This service is subject to receipt of government operating authority.

For more information on Baltia visit the company web site at: www.baltia.com.

Contact Information:

William E. Kassar, Jr.
Director, Investor Relations
Baltia Air Lines
JFK – (718) 917-8052
Mobile – (516) 375-9130

SOURCE: Baltia Air Lines, Inc.

ReleaseID: 442874

DOVER, DE / ACCESSWIRE / July 26, 2016 / Metatron Inc. (MRNJ): Metatron is pleased to report our, “Ultimate Guide to Pokémon Tips and Tricks,” has been submitted to Google Play and we expect to be on sale later today, subject to Google approval. We expect to have an iOS version on sale in the next few weeks.

Pokémon has taken over the mobile gaming scene since its release on July 6. The game is a massive hit, with somewhere in the neighborhood of 21 or 22 million daily active users in the United States on July 20. It has become the most popular mobile game ever in the US on July 12, with nearly 21 million active daily users in the US. That edged out Candy Crush Saga at its peak, making Pokémon Go the most popular mobile game ever in the United States with 6% of the US population playing on any given day.

Other Company News:

Metatron is in the process of converting popular paid apps into free apps in order to promote its new niche content channel, similar to Netflix and Hulu. With over 1500 app spots on iTunes and Google Play we expect to generate a significant amount traffic to convert into paid subscribers.

Metatron’s Board of Directors declared a convertible stock dividend in the amount of 1 share of preferred B stock for every 100,000 shares of the Corporation’s common stock held. August 25th 2016, is hereby fixed as the record date for the determination of stockholders entitled to receive payment of such dividend, and October 1st 2016 is hereby fixed as the dividend payment date, pending approval from FINRA. Fractional shares will be rounded up.

We recently released the Cannaboids app which was created our i-Mobilize app division for all major app stores. The apps are based on our CDB portal and brand cannaboids.com.

Metatron announced an agreement with Trinity Healers and Fleet Management who are distributors of CBD Naturals Water to market their products within our current and future cannabis mobile apps.

Cannaboids Android Version
Download: http://bit.ly/29iTDkh
Cannaboids iOS Version
Download: http://apple.co/299vKka

Our YouTube based paid subscription site MarkSargent.com is live and we are pleased with the performance of our new platform. Be sure to sign up now free for a limited time: MarkSargent.com, one of the top conspiracy sites. Our MyShowNetwork platform helps convert popular YouTube channel free followers into paid subscribers.

Metatron provides digital content distribution across most major mobile device platforms. Through its app division iMobilize, the company was an early pioneer in the App industry. Metatron conceives, creates, and monetizes content for its customers in order to reach a global audience.

We have 700+ apps on sale now with over 3 million in sales and downloads. Our focus lies in the health, fitness, and entertainment categories. High profile clients include Eckhart Tolle, Mark Sargent, Jafree Ozwald, Sounds True, Gary Zukav, Denise Druce, Mind Motivations, Effective Learning Systems, Travelvideostore.com and many others.

Website: http://metatroninc.com/
Facebook: http://www.facebook.com/metatroninc
Facebook: http://www.facebook.com/iMobilize
News: https://metatroninc.wordpress.com
Twitter: http://twitter.com/metatroninc
Apps: iTunes: https://itunes.apple.com/us/artist/i-mobilize-inc./ id325075390
Google Play: https://play.google.com/store/apps/ developer?id=Metatron+Inc

MRNJ Stock Discussion Boards

http://investorshub.advfn.com/boards/board.aspx?board_id=11733

Forward-Looking Statements: Any statements made in this press release which are not historical facts contain certain forward-looking statements, as such term is defined in the Private Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results of the specific items described in this release, and the company’s operations generally, to differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company’s need for additional financing, which is not assured and which may result in dilution of shareholders, the company’s status as a small company with a limited operating history, dependence on third parties and the continuing popularity of the iOS operating system, general market and economic conditions, technical factors, receipt of revenues, and other factors, many of which are beyond the control of the company. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of such statements, and we disclaim any obligation to update information contained in any forward-looking statement. Metatron retained Pacific Equity Alliance LLC by issuing Integrative Business Alliance LLC 100m rule 144 for 1 year consulting services.

Metatron does not grow, sell or distribute any substances that violate United States Law or the controlled substance act.

CONTACT:

Website: http://www.metatroninc.com
Phone: 302-861-0431

Press Release Information:
Investor Relations: PACIFIC EQUITY ALLIANCE LLC
Investor Contact(s): Zachary R. Logan / Grady Powell
C o n t a c t p h o n e : 8 5 8 . 8 8 6 . 7 2 3 8
info@pacif8ificequityusa.com

 

Zachary R. Logan
President

 

PACIFIC EQUITY ALLIANCE LLC

WWW.PACIFICEQUITYUSA.COM
WWW.INVESTORSPOTLIGHTDAILY.COM
858.886.7237
858.886.723

 

Disclaimer: Pacific Equity Alliance, LLC is an Independent Investor Relations firm that provides information on selected publicly traded companies. Pacific Equity Alliance, LLC is not a United States Securities Dealer or Broker or United States registered Investment Adviser. This email letter and any and all attachments and related documents are never considered to be a solicitation for any purpose in any form or content. Pacific Equity Alliance, LLC.’s Affiliates, Officers, Directors and Employees will buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own due diligence before investing in any of the stocks mentioned above. Upon receipt of these documents you, as the Recipient, hereby acknowledge this Warning and Disclaimer. These Confidential communications are protected under GrammLeach-Bailey Act 15 USC, Sub chapter 1, sections 6801-6809 and other laws addressing the disclosure of Non-Public Personal Information.

Confidential: The contents of this message, together with any attachments, are intended only for the use of the individual or entity to which they are addressed and may contain information that s legally privileged, confidential and exempt from disclosure. This communication is for information purposes only and should not be regarded as an offer to sell or as a solicitation of an offer to buy any financial product, an official confirmation of any transaction, or as an official statement of the Sender or its Principals. Email transmission cannot be guaranteed to be secure or error-free. The Sender, its affiliates and or assigns does not represent that this information is complete or accurate and it should not be relied upon as such. All information is subject to change without notice. If you are not the intended recipient, you are hereby notified that any dissemination, distribution, or copying of this message, or any attachment, is strictly prohibited. If you have received this message in error, please notify the original sender by return E-mail and delete this message, along with any attachments, from your computer.

SOURCE: Metatron Inc.

ReleaseID: 442872

IRVINE, CA / ACCESSWIRE / July 26, 2016 / Khang & Khang LLP (the “Firm”) announces that a class action lawsuit was filed against TransEnterix, Inc. (“TransEnterix” or the “Company”) (NYSE MKT: TRXC). Investors who purchased or otherwise acquired shares between February 10, 2016 and May 10, 2016 inclusive (the “Class Period”), are encouraged to contact the Firm before the August 1, 2016 lead plaintiff motion deadline.

If you purchased shares of TransEnterix during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

The complaint alleges that throughout the Class Period, TransEnterix made false and/or misleading statements and/or failed to disclose that: there were deficiencies within the Company’s 510(k) submission regarding the SurgiBot that undermined the likelihood that the SurgiBot would receive clearance from the Food and Drug Administration, which would leave TransEnterix unable to commercialize the SurgiBot in 2016, and would impair the Company’s ability to obtain approval for and commercialize its other robotic surgery platform in the United States.

If you wish to learn more about this lawsuit, or if you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contacts

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 442871

VANCOUVER, BC / ACCESSWIRE / July 26, 2016 / CanAlaska Uranium Ltd. (TSXV: CVV) (OTCQB: CVVUF) (FSE: DH7N), (“CanAlaska” or the “Company”) is pleased to report that Cameco’s (Cameco Corporation (TSX: CCO) (NYSE: CCJ)) exploration team will resume drilling shortly at CanAlaska’s West McArthur project along trend from Cameco’s high-grade Fox Lake uranium discovery. Makena Resources will also be drilling at the Company’s West Patterson property to followup the first drill hole that encountered radioactivity along the entire length of rock tested.

Cameco to Resume Drilling Along Trend of High-Grade Fox Lake Discovery 

Cameco’s uranium exploration team has now established access to the C10 conductor targets south of drill hole WMA035, which was drilled in April of this year. This planned drilling, announced on May 31, has been delayed because of ground conditions which hampered summer access. Drilling is scheduled to commence in late July or early August.

CanAlaska Cameco Option Map

To view an enhanced version of CanAlaska Cameco Option Map, please visit: https://www.accesswire.com/uploads/CanALASKA2221.jpg.

CanAlaska and Cameco are exploring the West McArthur Uranium project under a $12.5 million Agreement. The project covers 35,830 hectares (88,536 acres) commencing 6 kilometres (4 miles) northwest of Cameco’s majority owned McArthur River uranium mine. Importantly, West McArthur is immediately adjacent to Cameco’s recently disclosed Fox Lake uranium discovery with reported inferred resources of approximately 68.1 million pounds based on 387,000 tonnes at 7.99% U3O8. The Fox Lake discovery is within the Read Lake project operated by Cameco (Cameco 78.2%, Areva 21.8%). For more information about the West McArthur project visit http://www.canalaska.com/s/West_McArthur.asp?ReportID=560713.

Makena to Resume Drilling on Large Gravity Target on West Patterson Property

Makena Resources Inc. has scheduled the next phase of drilling at the West Patterson prospect in the Athabasca basin of Saskatchewan for early August. Makena anticipates the drill program to consist of at least three to five holes. A previous drill hole intersected a continuous section of anomalous radiometric response over the entire 113 metres of basement intersection. Shearing and brecciation occurs all along the 113 metres of granitic basement core, associated with clay alteration and alternating bleached and hematized sections down to the end-of-hole.

 

Patterson Lake Project Radiometric Log

To view an enhanced version of Patterson Lake Project Radiometric Log, please visit: https://www.accesswire.com/uploads/CanALASKA2222.jpg.

CanAlaska’s West Patterson Lake property is located in the southwestern Athabasca Basin, approximately 10 kilometres northwest of NexGen Energy’s Rook I project and Fission Uranium’s Triple R deposit. For further information see http://www.canalaska.com/s/News.asp?ReportID=731650.

CanAlaska president, Peter Dasler states, “Cameco’s drill program is aimed to test uranium mineralized alteration zones, which were intersected in previous drilling. This second round exploration has an excellent chance of intersecting further uranium mineralization closer to the centre of the mineral system in this highly prospective area. Makena’s previous drilling has shown that there is anomalous uranium mineralization in the target area. We expect this drilling will vector towards a larger uranium target in the centre of a prominent gravity anomaly.”

About Cameco Corporation

Cameco is one of the world’s largest uranium producers, a significant supplier of conversion services and one of two Candu fuel manufacturers in Canada. The company’s competitive position is based on controlling ownership of the world’s largest high-grade reserves and low-cost operations. Cameco’s uranium products are used to generate clean electricity in nuclear power plants around the world. Headquartered in Saskatoon, Saskatchewan, the company also explores for uranium in the Americas, Australia and Asia. Shares of Cameco trade on the Toronto and New York stock exchanges. Further information on Cameco can be found at www.cameco.com.

About CanAlaska Uranium

CanAlaska Uranium Ltd. (TSXV: CVV) (OTCQB: CVVUF) (FSE: DH7N) holds interests in approximately 500,000 hectares (1.2 million acres), one of the largest land positions in Canada’s Athabasca Basin region – the “Saudi Arabia of Uranium.” CanAlaska’s strategic holdings has attracted major international mining companies Cameco, Denison, KORES, KEPCO, and the De Beers Group of Companies. CanAlaska is a project generator and is positioned for discovery success in the world’s richest uranium district. For further information visit www.canalaska.com.

The qualified technical person for this news release is Dr Karl Schimann, P. Geo, VP Exploration, for CanAlaska.

On behalf of the Board of Directors

“Peter Dasler”

Peter Dasler, M.Sc., P.Geo.
President & CEO ;
CanAlaska Uranium Ltd.

Contacts:

Peter Dasler, President
CanAlaska Uranium Ltd.
Tel: +1.604.688.3211 x138
Email: info@canalaska.com

John Gomez, Corporate Development
CanAlaska Uranium Ltd.
Tel: +1.604.484.7118
Email: jgomez@canalaska.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking information

All statements included in this press release that address activities, events or developments that the Company expects, believes or anticipates will or may occur in the future are forward-looking statements. These forward-looking statements involve numerous assumptions made by the Company based on its experience, perception of historical trends, current conditions, expected future developments and other factors it believes are appropriate in the circumstances. In addition, these statements involve substantial known and unknown risks and uncertainties that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will prove inaccurate, certain of which are beyond the Company’s control. Readers should not place undue reliance on forward-looking statements. Except as required by law, the Company does not intend to revise or update these forward-looking statements after the date hereof or revise them to reflect the occurrence of future unanticipated events.

SOURCE: CanAlaska Uranium Ltd.

ReleaseID: 442869

IRVINE, CA / ACCESSWIRE / July 26, 2016 / Khang & Khang LLP (the “Firm”) announces that a class action lawsuit was filed against Stericycle, Inc. (“Stericycle” or the “Company”) (NASDAQ: SRCL, SRCLP). Investors who purchased or otherwise acquired shares between February 7, 2013 and April 28, 2016 inclusive (the “Class Period”), are encouraged to contact the Firm prior to the September 12, 2016 lead plaintiff motion deadline.

If you purchased shares of Stericycle during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

The complaint alleges that during the Class Period, Stericycle failed to disclose that it engaged in a scheme whereby it routinely raised the rates it charged smaller customers in violation its contracts with those customers. This inflated revenues and growth. On October 22, 2015, the Company announced disappointing growth rates and revenues during the third quarter of 2015. On April 28, 2016, Stericycle disclosed its results for the first quarter of 2016 which were again below expectations. When this news was announced, the Company’s stock price fell significantly.

If you wish to learn more about this lawsuit, or if you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contacts

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 442868